Login
$ADPT
$26.27 +$0.76 (2.98%) Close

Insider Transactions

What Adaptive Biotechnologies Corporation's executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.

Insider trades

3 months 12 months
Open-market buys 0 0
Sells 49 162
Total trades 79 306

Shares traded

3 months 12 months
Acquired 976,210 5,244,871
Disposed 1,145,502 7,079,044
Net activity −169,292 −1,834,173

See the story behind these numbers

View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.

Open-market buyer Disclosed 10b5-1 Heavy discretionary Sign up free

All transactions

Insider Relation Date Transaction Shares Price Value Shares held
Rubinstein Julie President and COO Oct 26 Disclosed 10b5-1 sale · S −3,378 $26.30 −$88.8K 377,802
Rubinstein Julie President and COO Oct 26 Disclosed 10b5-1 sale · S −8,503 $25.94 −$221K 381,180
Rubinstein Julie President and COO Oct 26 Exercise / conversion · M +11,881 $12.14 +$144K 389,683
Rubinstein Julie President and COO Oct 23 Disclosed 10b5-1 sale · S −7,381 $25.28 −$187K 377,802
Rubinstein Julie President and COO Oct 23 Disclosed 10b5-1 sale · S −4,500 $24.50 −$110K 385,183
Rubinstein Julie President and COO Oct 23 Exercise / conversion · M +11,881 $12.14 +$144K 389,683
Rubinstein Julie President and COO Oct 22 Disclosed 10b5-1 sale · S −1,700 $25.29 −$43K 377,802
Rubinstein Julie President and COO Oct 22 Disclosed 10b5-1 sale · S −10,181 $24.38 −$248K 379,502
Rubinstein Julie President and COO Oct 22 Exercise / conversion · M +11,881 $12.14 +$144K 389,683
Rubinstein Julie President and COO Oct 21 Disclosed 10b5-1 sale · S −5,882 $25.57 −$150K 377,802
Rubinstein Julie President and COO Oct 21 Disclosed 10b5-1 sale · S −5,999 $25.25 −$151K 383,684
Rubinstein Julie President and COO Oct 21 Exercise / conversion · M +11,881 $12.14 +$144K 389,683
Rubinstein Julie President and COO Oct 20 Disclosed 10b5-1 sale · S −100 $24.85 −$2.49K 377,802
Rubinstein Julie President and COO Oct 20 Disclosed 10b5-1 sale · S −11,781 $24.53 −$289K 377,902
Rubinstein Julie President and COO Oct 20 Exercise / conversion · M +11,881 $12.14 +$144K 389,683
Rubinstein Julie President and COO Oct 19 Disclosed 10b5-1 sale · S −11,881 $24.05 −$286K 377,802
Rubinstein Julie President and COO Oct 19 Exercise / conversion · M +11,881 $12.14 +$144K 389,683
Rubinstein Julie President and COO Oct 16 Disclosed 10b5-1 sale · S −300 $25.45 −$7.64K 377,802
Rubinstein Julie President and COO Oct 16 Disclosed 10b5-1 sale · S −11,581 $24.21 −$280K 378,102
Rubinstein Julie President and COO Oct 16 Exercise / conversion · M +11,881 $12.14 +$144K 389,683

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support